Wet age-related macular degeneration AMD , a leading cause of vision impairment , has historically posed significant challenges for eye doctors . Now, the drug vanucizumab is showing promise as a promising therapeutic approach . This innovative therapy inhibits vascular endothelial growth VEGF , a key element driving abnormal tiny vessel growth in